This topic contains a solution. Click here to go to the answer

Author Question: Thompson Manufacturing has been designated a recalcitrant employer by OSHA. As a result, Thompson ... (Read 148 times)

frankwu

  • Hero Member
  • *****
  • Posts: 549
Thompson Manufacturing has been designated a recalcitrant employer by OSHA. As a result, Thompson will most likely ________.
 
  A) receive a stern warning
  B) close its facilities immediately
  C) experience numerous inspections
  D) downsize its staff and hire contractors

Question 2

Approximately, how many inspectors does OSHA have?
 
  A) 500
  B) 2,200
  C) 2,700
  D) 22,000



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ansleighelindsey

  • Sr. Member
  • ****
  • Posts: 364
Answer to Question 1

Answer: C

Answer to Question 2

Answer: B




frankwu

  • Member
  • Posts: 549
Reply 2 on: Jul 6, 2018
Great answer, keep it coming :)


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library